1. Lyon, France: IARC press; 2008. WHO classification of tumours of haematopoietic and lymphoid tissues;Swerdlow,2008
2. SEER cancer statistics review, 1975-2007,2010
3. Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma;San Miguel;N Engl J Med,2008
4. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma;Benboubker;N Engl J Med,2014
5. Phase 3 randomized study of daratumumab plus lenalidomide and dexamethasone (D-Rd) Versus lenalidomide and dexamethasone (Rd) in patients with newly diagnosed multiple myeloma (NDMM) ineligible for transplant (MAIA);Facon;Blood,2018